Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ironwood Pharmaceuticals (IRWD) Return on Invested Capital: 2021-2025

Historic Return on Invested Capital for Ironwood Pharmaceuticals (IRWD) over the last 2 years, with Sep 2025 value amounting to -0.95%.

  • Ironwood Pharmaceuticals' Return on Invested Capital was N/A to -0.95% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.95%, marking a year-over-year change of. This contributed to the annual value of -0.26% for FY2024, which is N/A change from last year.
  • Ironwood Pharmaceuticals' Return on Invested Capital amounted to -0.95% in Q3 2025, which was down 340.78% from -0.22% recorded in Q2 2025.
  • Ironwood Pharmaceuticals' Return on Invested Capital's 5-year high stood at 1.98% during Q1 2021, with a 5-year trough of -0.95% in Q3 2025.
  • For the 3-year period, Ironwood Pharmaceuticals' Return on Invested Capital averaged around -0.24%, with its median value being -0.19% (2024).